Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Antibody-Drug-Conjugates (ADCs) & Breast Cancer / Mammacarcinoma (TNBC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

The advent of antibody-drug conjugates (ADC), able to deliver selectively potent chemotherapeutic agents, has demonstrated promising clinical activity
Zardavas 2022 Expert Opinion on Investigational Drugs 31(6): 633-644

…

References (Sources)

Antibody drug conjugates for patients with breast cancer
Medford et al. 2021 Current Problems in Cancer 45: 100795
Antibody–drug conjugates in breast cancer: the chemotherapy of the future?
Nicolò et al. 2020 Curr Opin Oncol 32: 494-502
Review
Antibody–drug conjugates in triple negative breast cancer
Tray et al. 2018 Future Oncology 14: 2651–2661
Review
Clinical development of antibody-drug conjugates in triple negative breast cancer: can we jump higher?
Zardavas 2022 Expert Opinion on Investigational Drugs 31(6): 633-644
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Antibody-Drug-Conjugates (ADCs) & Breast Cancer / Mammacarcinoma (TNBC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat